| Status: AWMSG assessment in progress | |
For the off label treatment of moderate to severe hidradenitis suppurativa that does not respond to licensed treatment or where licensed treatments are contraindicated. |
|
Medicine details |
|
| Medicine name | infliximab |
| Formulation | intravenous infusion |
| Reference number | 10020 |
| Indication | As above |
| Company | various |
| BNF chapter | Skin |
| Assessment type | One Wales |
| Status | AWMSG assessment in progress |
| Scrutiny Panel meeting date | 30/06/2026 |
| OWMAG meeting date | 05/10/2026 |
| AWMSG meeting date | 04/11/2026 |